AI
SQZ

Alphabet Inc’s SQZ Biotechnologies Company SQZ Stock Holding History

Alphabet Inc’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-103,929
Closed -$500K – 62
2022
Q1 		$500K Hold
103,929
– – 0.02% 55
2021
Q4 		$928K Hold
103,929
– – 0.02% 53
2021
Q3 		$1.5M Hold
103,929
– – 0.04% 41
2021
Q2 		$1.5M Sell
103,929
-727,460
-87% -$9.5M 0.03% 34
2021
Q1 		$11.4M Hold
831,389
– – 0.46% 22
2020
Q4 		$24.1M Buy
+831,389
New +$21.2M 1.16% 15

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alphabet Inc's SQZ Position: Q2 2022 in Review

Alphabet Inc sold out of SQZ Biotechnologies Company (SQZ) in Q2 2022, closing a stake of 103,929 shares — an estimated $500K sold.

Alphabet Inc first reported a position in SQZ in Q4 2020 and held it in 6 quarters. The position peaked at $24.1M in Q4 2020. 53 funds tracked by Wall St. Rank hold SQZ as of Q2 2022.

  • Alphabet Inc reported no remaining SQZ Biotechnologies Company position as of Q2 2022 after selling out during the quarter.
  • Alphabet Inc sold 103,929 SQZ Biotechnologies Company shares in Q2 2022, an estimated $500K.
  • Alphabet Inc first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 6 quarters.
  • Alphabet Inc's SQZ Biotechnologies Company position peaked at $24.1M in Q4 2020.
  • 53 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2022.

Based on Alphabet Inc's 13F filing for Q2 2022, filed 15 Nov 2022.